The atherosclerotic cardiovascular disease market in the 7MM is expected to show positive growth during the forecast period (2025–2034), mainly attributed to the launch of upcoming therapies such as ...
Revolution Medicines surged on AbbVie buyout rumors but pulled back after denial. Learn what's next for RVMD stock and why it ...
Backed by more than a dozen prominent investors, the startup is advancing into human testing a drug it believes capable of ...
These businesses have both steadily increased their payouts. Lowe's is focusing on the lucrative professional contractor market. Pfizer is moving on to a new era of growth and profitable products.
Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already known about genes, diseases, treatments, molecular pathways and symptoms in ...
Scientists at the University of Colorado Anschutz have discovered that while brain neuron changes, including cell loss, may begin in early life, a drug long-approved for other conditions might be ...
When President Donald Trump declared in May that he wanted drug companies to voluntarily cut their prices, few pharmaceutical executives wanted to go first. Now, no one wants to be last – and risk the ...
Cytokinetics' heart-disease drug Myqorzo was approved by the Food and Drug Administration. The San Francisco biopharmaceutical company said Friday that Myqorzo had been approved in 5, 10, 15 and 20 ...
Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...
The Dow Jones tracks 30 of the largest American companies across different sectors. Verizon, Chevron, and Merck hold the highest dividend yields in the Dow Jones. Chevron, Merck, and Coca-Cola stand ...
Women with uterine fibroids had a disproportionately higher risk of atherosclerotic cardiovascular disease (ASCVD) in a study of real-world claims data. Fibroids may therefore be a marker for ...